SEC notices exemptive application from RTW Biotech Growth Fund over share classes
A routine but consequential SEC notice: RTW Biotech Growth Fund and RTW Investments, LP have applied for exemptive relief that would let the closed-end fund adopt a multi-class share structure with early withdrawal charges and asset-based fees. The notice opens a window for interested parties to request a hearing before the order issues.
- RTW Biotech Growth Fund and RTW Investments, LP filed the exemptive application on August 28, 2026.
- The applicants seek exemptions from sections 18(a)(2), 18(c) and 18(i) and rule 23c-3 of the Investment Company Act of 1940, plus an order under section 17(d) and rule 17d-1.
- Relief sought would permit multiple share classes, early withdrawal charges, and asset-based distribution and/or service fees.
- Hearing requests must be received by the Commission by 5:30 p.m. Eastern time on November 2, 2026, accompanied by proof of service on applicants.
- Absent a hearing order, the SEC will issue the requested exemptive order without further notice.